Small Molecule

Pfizer Partners with Enodia on Sec61 Programs

Enodia Therapeutics and Pfizer entered a multi-target research collaboration and license agreement to discover Sec61 inhibitors. Enodia will screen, optimize, and develop candidates during the collaboration term; Pfizer will assume clinical, manufacturing, regulatory, and…

Saturday Rounds

Agenus Raises Up to $340M on Neoadjuvant MSS Colon Cancer
Infinimmune Raises $75 Million for Two Atopic-Dermatitis Antibodies
GenScript Raises HK$2.33 Billion for AIDD Expansion
TriGemX Raises $94 Million for Phase 3 Migraine Trials